The Fourth Partnering “Russian Medicine. An interdisciplinary dialogue” took place in Kazan. This annual event, hosted by the Federal Antimonopoly Service, Health Ministry of Kazan, and the Association of the Russian Pharmaceutical Manufacturers, brought together over 200 people, of which representatives of industry companies, and state agencies.      At the opening speech the Head of […]

   The Eighth Annual conference “State regulation and the Russian Pharmaceutical Industry- 2016. Continuation of the dialogue” has been held in Moscow on March 31. The conference was a joint project of the Association of Russian Pharmaceutical Manufacturers (ARPM), Association of International Pharmaceutical Manufacturers (AIPM), Analytical company- DSM group, and  the Research institute on healthcare organization […]

The Third Partnering “Russian Medicines. An interdisciplinary dialogue” took place in Kazan on September 25. The main agenda of the meeting was drug provision and Federal Law 44 on contract system in public procurement. The event was organized by the Federal Antimonopoly Service, Ministry of Health of Tatrstan and the Association of the Russian Pharmaceutical […]

Pharma medical forum “Healthcare and the development of the pharmaceutical industry. An interdisciplinary dialogue”, which was organized by the Association of the Russian Pharmaceutical Manufacturers together with Health Ministry of Crimea and the Healthcare commuter of the State Duma took place in Yalta on July 7, 2015. Over 300 participants from state agencies and pharmaceutical […]

The first Pharmaceutical Camping in Altay has finished. It was a mutual educational project of the Association of the Russian Pharmaceutical Manufacturers and the Administration of the Altay region. The project is a part of the Seventh International Youth Management Forum “Altay. The point of growth- 2015”.             The program of events included practical studies […]

During action more than 300 representatives of a business community of Russia and the CIS countries, legislative and executive power and the pharmaceutical organizations discuss the most topical issues connected with development of branch, changes in the market and effective interaction of the pharmaceutical enterprises with state structures.